Search results
Results From The WOW.Com Content Network
Opko Health announced the initiation of a Phase 2 trial of Rayaldee as a treatment for mild-to-moderate COVID-19. After rising in the pre-market trading hours, Opko stock was down 0.63% at the ...
OPKO Health (OPK) closed the most recent trading day at $3.22, moving -0.92% from the previous trading session.
Disappointing Q1 results weighed on the healthcare stock. For premium support please call: 800-290-4726 more ways to reach us
Before you buy stock in Opko Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Opko Health ...
OPKO Health, Inc. (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven't stopped buying Simply Wall St October 30, 2022 at 5:04 AM
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". [ 2 ]
OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment. OPKO Health (OPK) Stock Gains 2.1% Despite Q2 Earnings Miss Skip to main content
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...